SKIMS Soura’s Clinical Haematology Department Conducts First Allogeneic Stem Cell/Bone Marrow Transplant for Thalassemia Major

Srinagar 21 January (KNB): Department of Clinical Haematology, SKIMS has for the first time in the Union Territory of Jammu & Kashmir performed a matched sibling Allogeneic Stem Cell / Bone Marrow transplant for a patient suffering from Beta Thalassemia Major. Earlier the Department performed the first Stem/Bone Marrow transplant on patients suffering from Aplastic Anemia.

A statement issued to Kashmir News Bureau said that Dr. Javid Rasool Bhat, Prof. & Head Clinical Haematology Department, informed that an eight year old boy from Bihar (class Ist student) diagnosed as Beta Thalassemia major at the age of 8 months was evaluated at AIIMS, New Delhi and was offered Bone Marrow Transplant as curative therapy. The approximate cost of this procedure was quoted as Rs. 10 Lacs.

“Since, the patient belonged to a very poor family and could not afford this costly treatment. He was brought by his parents to the Department of Clinical Haematology at SKIMS for his treatment. The only curative treatment option for him was Stem Cell Transplantation,” Dr. Javaid said “Fortunately, his sister’s bone marrow stem cells were found to be matching. So, the patient was taken for Allogeneic matched sibling transplant on 30/12/2020. Presently, the patient is doing well and is being planned for discharge in a few days.” 

He thanked Director SKIMS for all the support and said this will raise new hope for poor and deserving patients who need Bone Marrow transplant.

However, Director SKIMS, Dr. A. G. Ahangar, complimented the whole Department of Clinical Haematology including faculty members: Dr. Sajad Geelani, Addl. Prof., Dr. Reashma Roshan, Asstt. Prof. Dr. Afaq Ahmad Khan, Asstt. Prof. and Senior Residents (both Clinical & Lab. side), Resident staff as well as Paramedical Staff of Ward 5P, Technical Staff (Lab. Side) and Office Staff of Clinical Hematology Department including all other supportive Departments. 

“SKIMS has created a niche in conducting rare procedures which is benefitting poor patients,” said Dr Ahanger. (KNB)